dactinomycin has been researched along with phenylmethylsulfonyl fluoride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bang, YJ; Danielpour, D; Kim, KY; Kim, SJ; Myers, CE; O'Reilly, MA; Trepel, JB | 1 |
Bersani, L; Colotta, F; Lazzarin, A; Mantovani, A; Poli, G | 1 |
2 other study(ies) available for dactinomycin and phenylmethylsulfonyl fluoride
Article | Year |
---|---|
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
Topics: 1-Methyl-3-isobutylxanthine; Aprotinin; Blotting, Northern; Bucladesine; Cell Division; Cell Line; Cyclic AMP; Cycloheximide; Dactinomycin; DNA Replication; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leupeptins; Male; Pentoxifylline; Phenylmethylsulfonyl Fluoride; Prostatic Neoplasms; RNA, Neoplasm; Theophylline; Transcription, Genetic; Transforming Growth Factor beta; Tumor Cells, Cultured | 1992 |
Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Topics: Adolescent; Adult; Animals; Catalase; Cell Line; Cytotoxicity, Immunologic; Dactinomycin; Female; Free Radicals; Granulomatous Disease, Chronic; Humans; Immunosuppressive Agents; Isoflurophate; Male; Monocytes; Oxygen; Phenylmethylsulfonyl Fluoride; Protease Inhibitors; Sarcoma, Experimental; Superoxide Dismutase | 1985 |